全國服務咨詢熱線：
18860915427
18860915427
產品分類
Product Category詳細介紹
| 品牌 | absin | CAS | 1195768-06-9 |
|---|---|---|---|
| 分子式 | C24H24F3N5O5S3 | 純度 | ＞98% |
| 分子量 | 615.67 | 貨號 | abs810452 |
| 規格 | 5mg | 供貨周期 | 現貨 |
| 主要用途 | is an orally bioavailable inhibitor of B | 應用領域 | 化工,生物產業,農林牧漁,制藥/生物制藥,綜合 |
Dabrafenib Mesylate 1195768-06-9
| 產品描述 | |
| 描述 | Dabrafenib is an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. |
| 純度 | >98% |
| 儲存/保存方法 | Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 別名 | Dabrafenib Mesylate (GSK 2118436B);GSK-2118436 Mesylate; GSK2118436 Mesylate; GSK 2118436 Mesylate |
| 外觀 | Powder |
| 可溶性/溶解性 | DMSO: ≥ 36 mg/mL |
| 生物活性 | |
| 靶點 | B-Raf (V600E) ,B-Raf ,C-Raf |
| In vitro(體外研究) | Dabrafenib displayed compelling inhibitory activity in enzyme and cellular mechanistic assays, and in cell proliferation assays in B-RafV600E-driven melanoma lines, SKMEL28 and A375P F11 (IC50 = 3 and 8 nM, respectively), and colorectal carcinoma line Colo205 (IC50 = 7 nM). Dabrafenib has a minimal effect in vitro on cells with wild-type B-Raf (HFF IC50 = 3.0 μM) and in tumor cells not harboring the activating B-RafV600E mutation. It is highly selective, exhibiting >500-fold selectivity for B-RafV600E compared to most kinases screened. Significant activity (. Cellular inhibition of BRAFV600E kinase activity by dabrafenib resulted in decreased MEK and ERK phosphorylation and inhibition of cell proliferation through an initial G1 cell cycle arrest, followed by cell death. |
| In vivo(體內研究) | In a BRAFV600E-containing xenograft model of human melanoma, orally administered dabrafenib inhibited ERK activation, downregulated Ki67, and upregulated p27, leading to tumor growth inhibition. Dabrafenib is orally bioavailable, doesn’t significantly accumulate after multiple dosing, and causes a reduction of pERK that is sustained for up to 18 h post-dosing after 7 and 14 days of dosing. |
| 研究領域 | |
| 研究領域 | CancerTumor biomarkers Drug DiscoverySmall Molecule DrugLead Compound Discovery |
產品咨詢
電話
微信掃一掃
地址：上海市浦東新區新浩路58號申江科創園18棟
郵箱：fengmj@univ-bio.com
傳真：